How Long Can We Leave Patients With Pulmonary Arterial Hypertension on Oral Drug Monotreatment?

被引：0
作者：
Ogawa, Aiko [1 ]
Matsubara, Hiromi [1 ]
机构：
[1] Natl Hosp Org, Dept Clin Sci, Okayama Med Ctr, Kita Ku, Okayama 7011192, Japan
来源：
CIRCULATION JOURNAL | 2012年 / 76卷 / 05期
关键词：
SILDENAFIL CITRATE; PROGNOSTIC-FACTORS; SURVIVAL; THERAPY;
D O I：
10.1253/circj.CJ-12-0341
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1089 / 1090
页数：2
相关论文
共 50 条
  • [31] Oral Anticoagulation for Pulmonary Arterial Hypertension: Systematic Review and Meta-analysis
    Caldeira, Daniel
    Loureiro, Maria Jose
    Costa, Joao
    Pinto, Fausto J.
    Ferreira, Joaquim J.
    CANADIAN JOURNAL OF CARDIOLOGY, 2014, 30 (08) : 879 - 887
  • [32] Inhaled Iloprost Plus Oral Sildenafil in Patients With Severe Pulmonary Arterial Hypertension Delays the Need for Lung Transplantation
    Lopez-Meseguer, M.
    Berastegui, C.
    Monforte, V.
    Bravo, C.
    Domingo, E.
    Roman, A.
    TRANSPLANTATION PROCEEDINGS, 2013, 45 (06) : 2347 - 2350
  • [33] Long-Term Outcomes With Ambrisentan Monotherapy in Pulmonary Arterial Hypertension
    Blalock, Shannon E.
    Matulevicius, Susan
    Mitchell, Laura C.
    Reimold, Sharon
    Warner, John
    Peshock, Ronald
    Torres, Fernando
    Chin, Kelly M.
    JOURNAL OF CARDIAC FAILURE, 2010, 16 (02) : 121 - 127
  • [34] Effects of bosentan on peripheral endothelial function in patients with pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension
    Hirashiki, Akihiro
    Adachi, Shiro
    Nakano, Yoshihisa
    Kamimura, Yoshihiro
    Shimokata, Shigetake
    Takeshita, Kyosuke
    Murohara, Toyoaki
    Kondo, Takahisa
    PULMONARY CIRCULATION, 2016, 6 (02) : 168 - 173
  • [35] Impact of Pulmonary Capillary Wedge Pressure on Long-Term Mortality in Patients With Pulmonary Arterial Hypertension Treated With Parenteral Trepostinil
    Patel, Jignesh K.
    Rao, Youlan
    Strachan, Paul
    HEART LUNG AND CIRCULATION, 2018, 27 (02) : 183 - 189
  • [36] Outcome of mean pulmonary arterial pressure-based intensive treatment for patients with pulmonary arterial hypertension
    Sugiyama, Yoichi
    Matsubara, Hiromi
    Shimokawahara, Hiroto
    Ogawa, Aiko
    JOURNAL OF CARDIOLOGY, 2022, 80 (05) : 432 - 440
  • [37] Using Clinical Trial End Points to Risk Stratify Patients With Pulmonary Arterial Hypertension
    Waxman, Aaron B.
    Farber, Harrison W.
    CIRCULATION, 2015, 132 (22) : 2152 - 2161
  • [38] Sildenafil improves renal function in patients with pulmonary arterial hypertension
    Webb, David J.
    Vachiery, Jean-Luc
    Hwang, Lie-Ju
    Maurey, Julie O.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2015, 80 (02) : 235 - 241
  • [39] Pulmonary Arterial Hypertension in Patients Infected with the Human Immunodeficiency Virus
    Hon, Stephanie M.
    Alpizar-Rivas, Rodolfo M.
    Farber, Harrison W.
    CARDIOLOGY CLINICS, 2022, 40 (01) : 45 - 54
  • [40] Short-term improvement in pulmonary hemodynamics is strongly predictive of long-term survival in patients with pulmonary arterial hypertension
    Tiede, Henning
    Sommer, Natascha
    Milger, Katrin
    Voswinckel, Robert
    Bandorski, Dirk
    Schermuly, Ralph T.
    Weissmann, Norbert
    Grimminger, Friedrich
    Seeger, Werner
    Ghofrani, Hossein A.
    PULMONARY CIRCULATION, 2013, 3 (03) : 523 - +
12345